Healthcare Realty Trust Incorporated (HR) P/E Ratio History
Historical price-to-earnings valuation from 1994 to 2022
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 2, 2026, Healthcare Realty Trust Incorporated (HR) trades at a price-to-earnings ratio of -26.0x, with a stock price of $18.45 and trailing twelve-month earnings per share of $-1.05.
The current P/E is 119% below its 5-year average of 139.0x. Over the past five years, HR's P/E has ranged from a low of 35.4x to a high of 363.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Real Estate sector median P/E of 23.4x, HR trades at a 211% discount to its sector peers. The sector includes 170 companies with P/E ratios ranging from 1.8x to 176.8x.
Relative to the broader market, HR trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Outpatient medical offices and clinics peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
GMREGlobal Medical REIT Inc. | $499M | 120.0Lowest | -Best | -95% |
CHCTCommunity Healthcare Trust Incorporated | $487M | 220.8 | -Best | +134%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $20.85 | $0.09 | 225.2x | +197% |
| FY2022 Q2 | $27.20 | $0.16 | 171.4x | +126% | |
| FY2022 Q1 | $27.48 | $0.22 | 124.9x | +65% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $31.64 | $0.24 | 131.4x | +73% |
| FY2021 Q3 | $29.78 | $0.09 | 326.2x | +330% | |
| FY2021 Q2 | Wed Jun 30 2021 00:00:00 GM | $30.20 | $0.16 | 190.2x | +151% |
| FY2021 Q1 | Wed Mar 31 2021 00:00:00 GM | $30.32 | $0.64 | 47.7x | -37% |
| FY2020 Q4 | $29.60 | $0.58 | 51.2x | -33% | |
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $30.12 | $0.85 | 35.4x | -53% |
| FY2020 Q2 | $29.29 | $0.81 | 36.2x | -52% | |
| FY2020 Q1 | $27.93 | $0.28 | 99.8x | +31% | |
| FY2019 Q4 | $33.37 | $0.29 | 115.1x | +52% |
Average P/E for displayed period: 75.9x
See HR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HR Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare HR vs WELL
See how HR stacks up against sector leader Welltower Inc..
Start ComparisonFrequently Asked Questions
Is HR stock overvalued or undervalued?
HR trades at -26.0x P/E, below its 5-year average of 139.0x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does HR's valuation compare to peers?
Healthcare Realty Trust Incorporated P/E of -26.0x compares to sector median of 23.4x. The discount suggests lower growth expectations or higher risk.
What is HR's PEG ratio?
HR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1994-2022.